Parkinson’s disease sharply increases early risk after elective hip replacement
Elective total hip arthroplasty is usually framed as a predictable recovery pathway, but Parkinson’s disease changes that trajectory in clinically meaningful ways. In a nationwide matched analysis, patients with Parkinson’s disease faced more perioperative complications, a longer hospital stay, and a much higher chance of returning to the hospital within 90 days after surgery. The signal was not subtle: readmission climbed to 10.3% in the Parkinson’s group versus 5.8% in controls, with an odds ratio of 1.86 and a p value below 0.001.
The study used the Nationwide Readmissions Database from 2020 through 2022 and focused on adults undergoing elective primary THA on hospital day 0. After propensity score matching on demographics, payer type, hospital characteristics, calendar year, and comorbidities, the cohort included 12,143 procedures: 2,043 in patients with Parkinson’s disease and 10,100 in controls. Matching quality was strong, with all standardized mean differences below 0.1, making the postoperative divergence more difficult to dismiss as a baseline imbalance. The design does not eliminate confounding, but it does place the outcome gap squarely around the diagnosis itself and the frailty pattern that often travels with it.
Readmission was only part of the problem
The readmission curve was accompanied by a second, more concerning pattern: procedural escalation after discharge. Within 90 days, patients with Parkinson’s disease had reoperation rates of 3.3% compared with 0.9% in controls, and revision rates of 3.0% versus 0.7%, both with p values below 0.001. Those numbers matter because revision and reoperation after primary arthroplasty usually signal instability, mechanical failure, infection workup, or another complication severe enough to move care back to the operating room. For surgeons and hospital teams, the message is direct: postoperative vulnerability persists well beyond the index admission.
Several index-hospital complications also clustered more often in the Parkinson’s cohort. Blood transfusion, pneumonia, urinary tract infection, and hip dislocation all occurred at higher rates, each reaching statistical significance with p values at or below 0.015. In-hospital mortality remained low and similar between groups, so the excess risk was not driven by early death but by a broader burden of medical and mechanical complications. Even length of stay was longer in patients with Parkinson’s disease, while hospital charges did not differ significantly.
A 90-day readmission rate that nearly doubles after surgery is not a minor postoperative inconvenience.
Why Parkinson’s disease alters arthroplasty recovery
The biological rationale is familiar to clinicians who care for patients with Parkinson’s disease. Neuromuscular dysfunction affects gait, balance, muscle tone, and postural control, and those impairments can destabilize an implanted hip in the earliest phase of recovery. Rigidity and bradykinesia can make transfers, ambulation, and adherence to precautions harder, while tremor and impaired coordination may complicate rehabilitation. Add medical frailty, autonomic dysfunction, aspiration risk, urinary dysfunction, and reduced reserve, and the early postoperative window becomes a period of amplified hazard rather than routine convalescence.
Hip dislocation in particular fits this pattern. After arthroplasty, the implant depends on stable soft tissue mechanics and controlled movement while patients relearn safe mobility. Parkinsonian motor symptoms can work against both goals, especially in the first weeks after discharge when supervision is lighter and rehabilitation demands are highest. Pneumonia and urinary tract infection point to a different layer of risk: systemic complications that can disrupt recovery, prolong immobility, and trigger readmission even when the joint itself is not the immediate source of trouble.
What the national data can and cannot answer
The study’s strength lies in its size and contemporary national scope. Using a 2020 to 2022 administrative dataset allowed the investigators to capture a large real-world surgical population and compare outcomes in a matched design that balanced measured confounders across groups. The findings therefore speak to everyday elective arthroplasty practice, not just a specialized referral center.
Administrative data, however, cannot describe every clinical detail that matters at the bedside. The database cannot measure Parkinson’s disease severity, medication timing, frailty granularity, rehabilitation participation, implant selection, or the specific reason behind each readmission or revision. It also cannot determine whether some complications were preventable with different perioperative pathways. Even so, the consistency of the signal across readmission, reoperation, revision, and several index complications makes the overall pattern difficult to ignore.
Elective arthroplasty in this population may still be appropriate, but the care pathway needs to anticipate instability rather than react to it.
Perioperative planning should assume higher post-discharge vulnerability
The practical implications extend from preoperative counseling to postoperative surveillance. Patients with Parkinson’s disease considering elective THA should be counseled that the risk of early complications is higher than in patients without the disorder, and that the chance of needing readmission or another procedure within 90 days is materially increased. That matters for shared decision-making, discharge planning, home support, and coordination with neurology, rehabilitation, and orthopedics.
Enhanced optimization before surgery may include closer medication reconciliation, mobility assessment, aspiration-risk awareness, and planning for postoperative support that matches the patient’s motor limitations. After surgery, a lower threshold for follow-up, rehabilitation adjustment, and evaluation of dislocation symptoms or infection may be warranted. The study does not define a single best intervention, but it does show where the system is failing: after discharge, when motor symptoms, frailty, and routine recovery collide.
For elective hip replacement in Parkinson’s disease, the operative event is only the beginning of the risk window. The data point to a larger need for surveillance, rehabilitation intensity, and planning that extends well beyond the hospital stay.